Measles, mumps and rubella vaccine - Current safety issues

被引:2
|
作者
West, R [1 ]
Roberts, PM
机构
[1] Mem Univ Newfoundland, Fac Med, Dept Epidemiol & Microbiol, Div Community Hlth, St Johns, NF A1B 3V6, Canada
[2] Mem Univ Newfoundland, Sch Nursing, St Johns, NF A1B 3V6, Canada
关键词
D O I
10.2165/00063030-199912060-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The current state of knowledge regarding the safety of measles, mumps and rubella vaccine (MMR) is reviewed. Although there are known adverse reactions to the vaccine, the majority are relatively minor and have no long term consequences, and those that do have long term consequences are extremely rare. Contraindications, known adverse reactions that may follow MMR immunisation, publicised adverse events for which a causal association with MMR has not been established, and the complications that may follow an infection with wildtype measles, mumps or rubella, are discussed. The article also discusses, with examples, the misleading information that can be obtained on the internet and in the public press. It is vital that the general public have an understanding of the great benefits and low risks associated with the use of MMR vaccine, because it is important that they consent to the administration of MMR vaccine to their children in order to ensure the success of universal immunisation programmes and the control of measles, mumps and rubella. Therefore, it becomes increasingly important for health professionals to use innovative education methods to promote immunisation and counteract the incorrect and misleading information that is readily available on the internet and in the media.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [41] Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine
    Kansal, Naveen Kumar
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [42] EVALUATION OF A TRIVALENT MEASLES, MUMPS, RUBELLA VACCINE IN CHILDREN
    BLOOM, JL
    SCHIFF, GM
    GRAUBARTH, H
    LIPP, RW
    JACKSON, JE
    OSBORN, RL
    KENNY, MT
    JOURNAL OF PEDIATRICS, 1975, 87 (01): : 85 - 87
  • [43] RATIONAL USE OF MEASLES, MUMPS AND RUBELLA (MMR) VACCINE
    CARTER, H
    CAMPBELL, H
    DRUGS, 1993, 45 (05) : 677 - 683
  • [44] MENINGOENCEPHALITIS AFTER MEASLES-MUMPS-RUBELLA VACCINE
    RAMSAY, MEB
    RAO, M
    ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (11) : 1365 - 1365
  • [45] JAPAN TROUBLES WITH MEASLES-MUMPS-RUBELLA VACCINE
    YAWATA, M
    LANCET, 1994, 343 (8889): : 105 - 106
  • [46] TRANSVERSE MYELITIS AFTER MEASLES, MUMPS, AND RUBELLA VACCINE
    JOYCE, KA
    REES, JE
    BRITISH MEDICAL JOURNAL, 1995, 311 (7002): : 422 - 422
  • [47] A combination vaccine against measles, mumps, rubella and varicella
    Knuf, Markus
    Faber, Joerg
    Barth, Immanuel
    Habermehl, Pirmin
    DRUGS OF TODAY, 2008, 44 (04) : 279 - 292
  • [48] GAIT DISTURBANCES AFTER MEASLES, MUMPS, AND RUBELLA VACCINE
    PLESNER, AM
    LANCET, 1995, 345 (8945): : 316 - 316
  • [49] Measles, Mumps, Rubella Vaccine (Priorix™ GSK-MMR)A Review of its Use in the Prevention of Measles, Mumps and Rubella
    Keri Wellington
    Karen L. Goa
    Drugs, 2003, 63 : 2107 - 2126
  • [50] Intralesional immunotherapy of warts with mumps, measles and rubella vaccine
    Choi, Hoon
    Kim, Hae Ryun
    Na, Chan Ho
    Kim, Min Sung
    Shin, Bong Seok
    Choi, Kyu Chul
    JOURNAL OF DERMATOLOGY, 2012, 39 : 63 - 64